India, March 11 -- Monday, Intelligent Bio Solutions Inc. (INBS) announced its securities purchase agreements with various healthcare-focused institutional and accredited investors on March 8th, aiming to raise around $10.1 million.
The private placement, conducted as per Nasdaq rules, involves the issuance of either 2,223,333 common stock shares or pre-funded warrants.
Additionally, Series H-1 and Series H-2 warrants are included, allowing the purchase of up to 2,223,333 common stock shares each. The price per share or pre-funded warrant is fixed at $4.55.
Both Series H-1 and Series H-2 warrants can be exercised immediately upon issuance, each priced at $4.55 per share.
The H-1 warrants will remain valid for eighteen months post the SE...